Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Mar 15;346(Pt 3):671–677.

Neutral sphingomyelinase activity dependent on Mg2+ and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium falciparum.

K Hanada 1, T Mitamura 1, M Fukasawa 1, P A Magistrado 1, T Horii 1, M Nishijima 1
PMCID: PMC1220899  PMID: 10698693

Abstract

Sphingolipid metabolism and metabolites are important in various cellular events in eukaryotes. However, little is known about their function in plasmodial parasites. Here we demonstrate that neutral sphingomyelinase (SMase) involved in the sphingomyelin (SM) catabolism is retained by the intraerythrocytic parasite Plasmodium falciparum. When assayed in a neutral pH buffer supplemented with Mg(2+) and phosphatidylserine, an activity for the release of the phosphocholine group from SM was detected in parasite-infected, but not in uninfected, erythrocyte ghosts. The SMase activity in the parasite-infected erythrocyte ghosts was enhanced markedly by anionic phospholipids including unsaturated but not saturated phosphatidylserine. Mn(2+) could not substitute for Mg(2+) to activate SMase in parasite-infected erythrocyte ghosts, whereas both Mn(2+) and Mg(2+) activated mammalian neutral SMase. The specific activity level of SMase was higher in isolated parasites than in infected erythrocyte ghosts; further fractionation of lysates of the isolated parasites showed that the activity was bound largely to the membrane fraction of the parasites. The plasmodial SMase seemed not to hydrolyse phosphatidylcholine or phosphatidylinositol. The plasmodial SMase, but not SM synthase, was sensitive to scyphostatin, an inhibitor of mammalian neutral SMase, indicating that the plasmodial activities for SM hydrolysis and SM synthesis are mediated by different catalysts. Our finding that the malaria parasites possess SMase activity might explain why the parasites seem to have an SM synthase activity but no activity to synthesize ceramide de novo.

Full Text

The Full Text of this article is available as a PDF (166.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansorge I., Jeckel D., Wieland F., Lingelbach K. Plasmodium falciparum-infected erythrocytes utilize a synthetic truncated ceramide precursor for synthesis and secretion of truncated sphingomyelin. Biochem J. 1995 May 15;308(Pt 1):335–341. doi: 10.1042/bj3080335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Atkinson C. T., Aikawa M. Ultrastructure of malaria-infected erythrocytes. Blood Cells. 1990;16(2-3):351–368. [PubMed] [Google Scholar]
  3. Ballou L. R., Laulederkind S. J., Rosloniec E. F., Raghow R. Ceramide signalling and the immune response. Biochim Biophys Acta. 1996 Jun 11;1301(3):273–287. doi: 10.1016/0005-2760(96)00004-5. [DOI] [PubMed] [Google Scholar]
  4. Banting G., Benting J., Lingelbach K. A minimalist view of the secretory pathway in Plasmodium falciparum. Trends Cell Biol. 1995 Sep;5(9):340–343. doi: 10.1016/s0962-8924(00)89060-1. [DOI] [PubMed] [Google Scholar]
  5. Dickson R. C. Sphingolipid functions in Saccharomyces cerevisiae: comparison to mammals. Annu Rev Biochem. 1998;67:27–48. doi: 10.1146/annurev.biochem.67.1.27. [DOI] [PubMed] [Google Scholar]
  6. Elabbadi N., Ancelin M. L., Vial H. J. Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem J. 1997 Jun 1;324(Pt 2):435–445. doi: 10.1042/bj3240435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Elmendorf H. G., Haldar K. Plasmodium falciparum exports the Golgi marker sphingomyelin synthase into a tubovesicular network in the cytoplasm of mature erythrocytes. J Cell Biol. 1994 Feb;124(4):449–462. doi: 10.1083/jcb.124.4.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grellier P., Rigomier D., Clavey V., Fruchart J. C., Schrevel J. Lipid traffic between high density lipoproteins and Plasmodium falciparum-infected red blood cells. J Cell Biol. 1991 Jan;112(2):267–277. doi: 10.1083/jcb.112.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haldar K., Uyetake L., Ghori N., Elmendorf H. G., Li W. L. The accumulation and metabolism of a fluorescent ceramide derivative in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol. 1991 Nov;49(1):143–156. doi: 10.1016/0166-6851(91)90137-u. [DOI] [PubMed] [Google Scholar]
  10. Hanada K., Hara T., Fukasawa M., Yamaji A., Umeda M., Nishijima M. Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferase. J Biol Chem. 1998 Dec 11;273(50):33787–33794. doi: 10.1074/jbc.273.50.33787. [DOI] [PubMed] [Google Scholar]
  11. Hanada K., Horii M., Akamatsu Y. Functional reconstitution of sphingomyelin synthase in Chinese hamster ovary cell membranes. Biochim Biophys Acta. 1991 Nov 5;1086(2):151–156. doi: 10.1016/0005-2760(91)90002-y. [DOI] [PubMed] [Google Scholar]
  12. Hanada K., Nishijima M., Kiso M., Hasegawa A., Fujita S., Ogawa T., Akamatsu Y. Sphingolipids are essential for the growth of Chinese hamster ovary cells. Restoration of the growth of a mutant defective in sphingoid base biosynthesis by exogenous sphingolipids. J Biol Chem. 1992 Nov 25;267(33):23527–23533. [PubMed] [Google Scholar]
  13. Hannun Y. A. Functions of ceramide in coordinating cellular responses to stress. Science. 1996 Dec 13;274(5294):1855–1859. doi: 10.1126/science.274.5294.1855. [DOI] [PubMed] [Google Scholar]
  14. Holz G. G., Jr Lipids and the malarial parasite. Bull World Health Organ. 1977;55(2-3):237–248. [PMC free article] [PubMed] [Google Scholar]
  15. Hostetler K. Y., Yazaki P. J. The subcellular localization of neutral sphingomyelinase in rat liver. J Lipid Res. 1979 May;20(4):456–463. [PubMed] [Google Scholar]
  16. Hsiao L. L., Howard R. J., Aikawa M., Taraschi T. F. Modification of host cell membrane lipid composition by the intra-erythrocytic human malaria parasite Plasmodium falciparum. Biochem J. 1991 Feb 15;274(Pt 1):121–132. doi: 10.1042/bj2740121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ikezawa H., Matsushita M., Tomita M., Taguchi R. Effects of metal ions on sphingomyelinase activity of Bacillus cereus. Arch Biochem Biophys. 1986 Sep;249(2):588–595. doi: 10.1016/0003-9861(86)90037-8. [DOI] [PubMed] [Google Scholar]
  18. Inselburg J. Gametocyte formation by the progeny of single Plasmodium falciparum schizonts. J Parasitol. 1983 Jun;69(3):584–591. [PubMed] [Google Scholar]
  19. Karlsson K. A. Sphingolipid long chain bases. Lipids. 1970 Nov;5(11):878–891. doi: 10.1007/BF02531119. [DOI] [PubMed] [Google Scholar]
  20. Lambros C., Vanderberg J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979 Jun;65(3):418–420. [PubMed] [Google Scholar]
  21. Lauer S. A., Ghori N., Haldar K. Sphingolipid synthesis as a target for chemotherapy against malaria parasites. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9181–9185. doi: 10.1073/pnas.92.20.9181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Liu B., Hassler D. F., Smith G. K., Weaver K., Hannun Y. A. Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J Biol Chem. 1998 Dec 18;273(51):34472–34479. doi: 10.1074/jbc.273.51.34472. [DOI] [PubMed] [Google Scholar]
  23. Merrill A. H., Jr, Wang E. Enzymes of ceramide biosynthesis. Methods Enzymol. 1992;209:427–437. doi: 10.1016/0076-6879(92)09053-6. [DOI] [PubMed] [Google Scholar]
  24. Nara F., Tanaka M., Hosoya T., Suzuki-Konagai K., Ogita T. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties. J Antibiot (Tokyo) 1999 Jun;52(6):525–530. doi: 10.7164/antibiotics.52.525. [DOI] [PubMed] [Google Scholar]
  25. Nara F., Tanaka M., Masuda-Inoue S., Yamasato Y., Doi-Yoshioka H., Suzuki-Konagai K., Kumakura S., Ogita T. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J Antibiot (Tokyo) 1999 Jun;52(6):531–535. doi: 10.7164/antibiotics.52.531. [DOI] [PubMed] [Google Scholar]
  26. Pinto W. J., Wells G. W., Lester R. L. Characterization of enzymatic synthesis of sphingolipid long-chain bases in Saccharomyces cerevisiae: mutant strains exhibiting long-chain-base auxotrophy are deficient in serine palmitoyltransferase activity. J Bacteriol. 1992 Apr;174(8):2575–2581. doi: 10.1128/jb.174.8.2575-2581.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Projan S. J., Kornblum J., Kreiswirth B., Moghazeh S. L., Eisner W., Novick R. P. Nucleotide sequence: the beta-hemolysin gene of Staphylococcus aureus. Nucleic Acids Res. 1989 Apr 25;17(8):3305–3305. doi: 10.1093/nar/17.8.3305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rao B. G., Spence M. W. Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res. 1976 Sep;17(5):506–515. [PubMed] [Google Scholar]
  29. Schissel S. L., Schuchman E. H., Williams K. J., Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem. 1996 Aug 2;271(31):18431–18436. doi: 10.1074/jbc.271.31.18431. [DOI] [PubMed] [Google Scholar]
  30. Segers R. P., van der Drift A., de Nijs A., Corcione P., van der Zeijst B. A., Gaastra W. Molecular analysis of a sphingomyelinase C gene from Leptospira interrogans serovar hardjo. Infect Immun. 1990 Jul;58(7):2177–2185. doi: 10.1128/iai.58.7.2177-2185.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Spence M. W. Sphingomyelinases. Adv Lipid Res. 1993;26:3–23. [PubMed] [Google Scholar]
  32. Spiegel S., Merrill A. H., Jr Sphingolipid metabolism and cell growth regulation. FASEB J. 1996 Oct;10(12):1388–1397. doi: 10.1096/fasebj.10.12.8903509. [DOI] [PubMed] [Google Scholar]
  33. Tomiuk S., Hofmann K., Nix M., Zumbansen M., Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3638–3643. doi: 10.1073/pnas.95.7.3638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Trager W., Jensen J. B. Human malaria parasites in continuous culture. Science. 1976 Aug 20;193(4254):673–675. doi: 10.1126/science.781840. [DOI] [PubMed] [Google Scholar]
  35. Vial H. J., Thuet M. J., Philippot J. R. Phospholipid biosynthesis in synchronous Plasmodium falciparum cultures. J Protozool. 1982 May;29(2):258–263. doi: 10.1111/j.1550-7408.1982.tb04023.x. [DOI] [PubMed] [Google Scholar]
  36. Ward G. E., Miller L. H., Dvorak J. A. The origin of parasitophorous vacuole membrane lipids in malaria-infected erythrocytes. J Cell Sci. 1993 Sep;106(Pt 1):237–248. doi: 10.1242/jcs.106.1.237. [DOI] [PubMed] [Google Scholar]
  37. Yamada A., Tsukagoshi N., Udaka S., Sasaki T., Makino S., Nakamura S., Little C., Tomita M., Ikezawa H. Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem. 1988 Aug 1;175(2):213–220. doi: 10.1111/j.1432-1033.1988.tb14186.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES